Bill > HB779

This bill establishes a comprehensive process for the administration of psychotropic medication to incarcerated individuals who refuse treatment in Maryland state correctional facilities. The bill creates a Medication Review Committee composed of a regional chief psychiatrist, another psychiatrist, and a non-physician mental health professional, which can approve involuntary administration of psychotropic medication under specific circumstances. These circumstances include situations where the incarcerated individual presents a danger to themselves or others, is suffering from a mental disorder that creates a likelihood of serious harm, and other treatment methods have been attempted. The bill provides significant procedural protections for the incarcerated individual, including the right to an impartial lay advisor, written notice of committee proceedings, the ability to attend and participate in the committee meeting (except during final deliberations), and an opportunity to present information and ask questions. If the committee approves medication, the decision must be documented in writing, specify medication details, and provide a right to administrative review. The medication administration cannot exceed 90 days without renewal, and the treating physician must document medication benefits and side effects every 15 days. The bill aims to balance the medical needs of mentally ill incarcerated individuals with their personal autonomy and due process rights.

Justice

Judiciary (House)

https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0779?ys=2025RS